Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice

American Journal of Pathology

Volumn 166, Issue 3, 2005, Pages 721-728

  Van Westerloo, David J ^a,b   Florquin, Sandrine ^a   De Boer, Anita M ^a   Daalhuisen, Joost ^a   De Vos, Alex F ^a   Bruno, Marco J ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMYLASE; CERULETIDE; COLLAGEN; HYDROXYPROLINE; INTERLEUKIN 6; LAMININ; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; TROGLITAZONE; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PANCREAS INJURY; PRIORITY JOURNAL; STELLATE CELL;

EID: 14644426005     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62293-6     Document Type: Article

References (41)

1. Banks PA: Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis. Gastrointest Endosc 2002, 56:S226-S230
2. Etemad B, Whitcomb DC: Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001, 120: 682-707
3. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grunert A, Adler G: Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998, 115:421-432
4. Schmid-Kotsas A, Gross HJ, Menke A, Weidenbach H, Adler G, Siech M, Beger H, Grunert A, Bachem MG: Lipopolysaccharide-activated macrophages stimulate the synthesis of collagen type 1 and C-fibronectin in cultured pancreatic stellate cells. Am J Pathol 1999, 155:1749-1758
5. Luttenberger T, Schmid-Kotsas A, Menke A, Siech M, Beger H, Adler G, Grunert A, Bachem MG: Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Invest 2000, 80:47-55
6. Jaskiewicz K, Nalecz A, Rzepko R, Sledzinski Z: Immunocytes and activated stellate cells in pancreatic fibrogenesis. Pancreas 2003, 26:239-242
7. Zhang X, Young HA: PPAR and immune system-what do we know? Int Immunopharmacol 2002, 2:1029-1044
8. Elangbam CS, Tyler RD, Lightfoot RM: Peroxisome proliferator-activated receptors in atherosclerosis and inflammation-an update. Toxicol Pathol 2001, 29:224-231
9. Masamune A, Kikuta K, Satoh M, Sakai Y, Satoh A, Shimosegawa T: Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells. J Biol Chem 2002, 277:141-147
10. Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G, Ridolfi F, Trozzi L, Surrenti C, Casini A: Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002, 122:1924-1940
11. Fu M, Zhang J, Zhu X, Myles DE, Willson TM, Liu X, Chen YE: Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J Biol Chem 2001, 276:45888-45894
12. Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB: Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int 2001, 59: 1899-1910
13. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82
14. Demols A, Van Laethem JL, Quertinmont E, Degraef C, Delhaye M, Geerts A, Deviere J: Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis. Am J Physiol 2002, 282:G1105-G1112
15. Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H, Nakagama H: Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 2003, 124:361-367
16. Bhatia M, Saluja AK, Singh VP, Frossard JL, Lee HS, Bhagat L, Gerard C, Steer ML: Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury. Am J Physiol 2001, 280:G974-G978
17. Woessner Jr JF: The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961, 93:440-447
18. Lichtman SN, Wang J, Hummel B, Lacey S, Sartor RB: A rat model of ileal pouch-rectal anastomosis. Inflamm Bowel Dis 1998, 4:187-195
19. Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, Pater J, van Rooijen N, van der Poll T: Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med 2003, 167:171-179
20. van Westerloo DJ, Schultz MJ, Bruno MJ, de Vos AF, Florquin S, van der Poll T: Acute pancreatitis in mice impairs bacterial clearance from the lungs, whereas concurrent pneumonia prolongs the course of pancreatitis. Crit Care Med 2004, 32:1997-2001
21. Muller-Pillasch F, Menke A, Yamaguchi H, Elsasser HP, Bachem M, Adler G, Gress TM: TGFbeta and the extracellular matrix in pancreatitis. Hepatogastroenterology 1999, 46:2751-2756
22. Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, Crawford DH, Pirola RC, McCaughan GW, Ramm GA, Wilson JS: Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 1999, 155:1087-1095
23. de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC: Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996, 83:349-353
24. Parker JC: Troglitazone: the discovery and development of a novel therapy for the treatment of type 2 diabetes mellitus. Adv Drug Deliv Rev 2002, 54:1173-1197
25. Stumvoll M, Haring HU: Glitazones: clinical effects and molecular mechanisms. Ann Med 2002, 34:217-224
26. Grimble RF: Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 2002, 5:551-559
27. Brady M, Christmas S, Sutton R, Neoptolemos J, Slavin J: Cytokines and acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol 1999, 13:265-289
28. Cuzzocrea S, Pisano B, Dugo L, lanaro A, Britti D, Patel NS, Paola RD, Genovese T, Rosa MD, Caputi AP, Thiemermann C: Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein. Intensive Care Med 2004, 30:951-956
29. Hashimoto K, Ethridge RT, Saito H, Rajaraman S, Evers BM: The PPARgamma ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis. Pancreas 2003, 27:58-66
30. Lee MS, Gu D, Feng L, Curriden S, Arnush M, Krahl T, Gurushanthaiah D, Wilson C, Loskutotf DL, Fox H: Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1. Am J Pathol 1995, 147:42-52
31. Van Laethem JL, Deviere J, Resibois A, Rickaert F, Vertongen P, Ohtani H, Cremer M, Miyazono K, Robberecht P: Localization of transforming growth factor beta 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology 1995, 108:1873-1881
32. Kon K, Ikejima K, Hirose M, Yoshikawa M, Enomoto N, Kitamura T, Takei Y, Sato N: Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem Biophys Res Commun 2002, 291:55-61
33. Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S, Nakazawa T, Ohara H, Nomura T, Joh T, Shirai T, Itoh M: Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 2003, 124: 1010-1019
34. Shimizu K, Shiratori K, Hayashi N, Kobayashi M, Fujiwara T, Horikoshi H: Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis. Pancreas 2002, 24: 184-190
35. Tsuruta S, Sutani T, Masuda J, Sakaguchi Y, Tsuchihashi M, Hashimoto T, Nakamura Y, Dohi K: Mechanism of cardiac involvement in the WBN/Kob rat. J Mol Cell Cardiol 1997, 29:247-253
36. Igarashi C, Maruyama T, Ezawa I, Takei I, Saruta T: WBN/Kob rat: a new model of spontaneous diabetes, osteopenia and systemic hemosiderin deposition. Bone Miner 1994, 27:133-144
37. Yagihashi S, Wada R, Kamijo M, Nagai K: Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes. Lab Invest 1993, 68:296-307
38. Vaquera E, Molero X, Tian X, Salas A, Malagelada JR: Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats. Gut 1999, 45:269-277
39. Arthur MJ: Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 2002, 122:1525-1528
40. Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, Ling MH, Albrecht J: Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002, 122:1303-1313
41. Wright MC, Issa R, Smart DE, Trim N, Murray Gl, Primrose JN, Arthur MJ, Iredale JP, Mann DA: Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001, 121:685-698